44 research outputs found

    Mitigation of fugitive dust impact arising from BR dry disposal

    Get PDF
    The development of international policies about environmental defense has enforced some major modifications in the management of industrial tailings. As regards the disposal of the residue deriving from the bauxite processing (BR) in the alumina industry, national and international regulations have encouraged the evolution from wet to dry disposal techniques. However, such a change in the storage practices poses a major concern due to the potential increase of the atmospheric impact in the surrounding areas, due to the emissions of Particulate Matter (PM) generated both by the BR disposal activities and by the wind erosion over the dried surfaces of the landfill. The article analyses the effect of the impact mitigation measures typically adopted to control PM emissions with reference to a major red mud basin located in the southwest of Sardinia (Italy). The PM dispersion models performed with the CALPUFF code (US EPA) allowed, for the case study under consideration, the estimate of the improvement provided by moistening the dry surfaces and reducing the total length travelled par year by the machinery involved in material handling, transportation and disposal

    PM emissions from a BR basin and impact assessment on air quality

    Get PDF
    The article deals with the emission of fugitive dust from a major BR (Bauxite Residue) basin located in the south-west of Sardinia, where the prospect of a change in the storage practices is likely to cause the increase of PM (Particulate Matter) pollution in the surrounding region. In fact, other natural and anthropic sources already provide a variable contribution in terms of airborne dust concentration in the same territory. In accordance with the procedures established by the Directive 2011/92 (EIA Directive - Environmental Impact Assessment), the data recorded by a monitoring network located in the SulcisIglesiente sub-region has been taken into consideration in order to define the ante-operam condition of the potential impact area. The additional contribution of the red mud basin has been simulated with the atmospheric dispersion model proposed by US EPA (Environmental Protection Agency). The expected whole concentration of the PM10, which includes both the pre-existing sources and the additional contribution of the red mud basin, has been estimated and compared with the limit values established by the Directive 2008/50/EC (Ambient air quality and cleaner air for Europe)

    Adherence issues related to sublingual immunotherapy as perceived by allergists

    Get PDF
    Objectives: Sublingual immunotherapy (SLIT) is a viable alternative to subcutaneous immunotherapy to treat allergic rhinitis and asthma, and is widely used in clinical practice in many European countries. The clinical efficacy of SLIT has been established in a number of clinical trials and meta-analyses. However, because SLIT is self-administered by patients without medical supervision, the degree of patient adherence with treatment is still a concern. The objective of this study was to evaluate the perception by allergists of issues related to SLIT adherence. Methods: We performed a questionnaire-based survey of 296 Italian allergists, based on the adherence issues known from previous studies. The perception of importance of each item was assessed by a VAS scale ranging from 0 to 10. Results: Patient perception of clinical efficacy was considered the most important factor (ranked 1 by 54% of allergists), followed by the possibility of reimbursement (ranked 1 by 34%), and by the absence of side effects (ranked 1 by 21%). Patient education, regular follow-up, and ease of use of SLIT were ranked first by less than 20% of allergists. Conclusion: These findings indicate that clinical efficacy, cost, and side effects are perceived as the major issues influencing patient adherence to SLIT, and that further improvement of adherence is likely to be achieved by improving the patient information provided by prescribers. © 2010 Scurati et al, publisher and licensee Dove Medical Press Ltd
    corecore